ATE294392T1 - Reagenz zur bestimmung von blutplättchen- mikroteilchen - Google Patents

Reagenz zur bestimmung von blutplättchen- mikroteilchen

Info

Publication number
ATE294392T1
ATE294392T1 AT01936518T AT01936518T ATE294392T1 AT E294392 T1 ATE294392 T1 AT E294392T1 AT 01936518 T AT01936518 T AT 01936518T AT 01936518 T AT01936518 T AT 01936518T AT E294392 T1 ATE294392 T1 AT E294392T1
Authority
AT
Austria
Prior art keywords
mpp
microparticles
platetic
reagent
determining
Prior art date
Application number
AT01936518T
Other languages
English (en)
Inventor
Michel Canton
Isabelle Botosezzy
Original Assignee
Biocytex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocytex filed Critical Biocytex
Application granted granted Critical
Publication of ATE294392T1 publication Critical patent/ATE294392T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
    • G01N2015/018—Platelets
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/1012—Calibrating particle analysers; References therefor
    • G01N2015/1014—Constitution of reference particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT01936518T 2000-05-16 2001-05-15 Reagenz zur bestimmung von blutplättchen- mikroteilchen ATE294392T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0006247A FR2809181B1 (fr) 2000-05-16 2000-05-16 Monoreactif pour le dosage des microparticules plaquettaires
PCT/FR2001/001468 WO2001088539A1 (fr) 2000-05-16 2001-05-15 Monoreactif pour le dosage des microparticules plaquettaires

Publications (1)

Publication Number Publication Date
ATE294392T1 true ATE294392T1 (de) 2005-05-15

Family

ID=8850288

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01936518T ATE294392T1 (de) 2000-05-16 2001-05-15 Reagenz zur bestimmung von blutplättchen- mikroteilchen

Country Status (9)

Country Link
US (1) US20030175831A1 (de)
EP (1) EP1282817B1 (de)
JP (1) JP4831915B2 (de)
AT (1) ATE294392T1 (de)
CA (1) CA2410008A1 (de)
DE (1) DE60110407T2 (de)
ES (1) ES2238442T3 (de)
FR (1) FR2809181B1 (de)
WO (1) WO2001088539A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090291086A1 (en) * 2001-02-21 2009-11-26 Alavita Pharmaceuticals, Inc. Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia
US7635680B2 (en) * 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
US20050222030A1 (en) * 2001-02-21 2005-10-06 Anthony Allison Modified annexin proteins and methods for preventing thrombosis
US7635676B2 (en) * 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
US7645739B2 (en) * 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same
CN101068570A (zh) * 2004-05-13 2007-11-07 贝林格尔·英格海姆国际有限公司 双嘧达莫治疗血小板抑制剂的抗药性的用途
JP4029298B2 (ja) * 2004-07-26 2008-01-09 大塚製薬株式会社 粘着性マイクロベシクルの除去方法
ATE509270T1 (de) * 2005-02-21 2011-05-15 Univ Saga Aus blutplättchen gewonnene mikropartikel als neue diagnosemarker für eine herz-kreislauf- erkrankung
GB2428471A (en) * 2005-07-18 2007-01-31 Mathshop Ltd Flow cytometry
SE531041C2 (sv) * 2006-07-17 2008-11-25 Hemocue Ab Räkning av trombocyter
FR2917172B1 (fr) * 2007-06-07 2014-01-03 Inst Nat Sante Rech Med Methode de mesure de l'activite plasmine des microparticules presentes dans un echantillon de fluide biologique et utilisation
US8062222B2 (en) * 2007-06-13 2011-11-22 Litron Laboratories, Ltd. Method for measuring in vivo hematotoxicity with an emphasis on radiation exposure assessment
JP2012168012A (ja) 2011-02-14 2012-09-06 Nippon Koden Corp 血管内皮障害を検査するための新規な検査方法および検査用キット
KR20140106550A (ko) 2011-11-30 2014-09-03 에이전시 포 사이언스, 테크놀로지 앤드 리서치 생물학적 모니터링을 위한 ｇｍ1 갱글리오사이드와 아넥신 ⅴ 마이크로입자 폴리펩타이드 비율
AU2015340109B2 (en) * 2014-10-30 2020-11-12 Erasmus University Medical Center Rotterdam Reagents, methods and kits for diagnosing primary immunodeficiencies
CN108463722B (zh) * 2016-03-30 2021-09-21 西门子医疗保健诊断公司 用于处理血小板细胞数据的系统、方法和设备
JP7444386B2 (ja) * 2018-06-07 2024-03-06 株式会社Ｌｓｉメディエンス ヒト尿からのマイクロベシクルの分離方法及び分析方法
JP7376021B2 (ja) * 2018-06-07 2023-11-08 株式会社Ｌｓｉメディエンス ヒト血液からのマイクロベシクルの分離方法及び分析方法
CN111896736A (zh) * 2020-08-04 2020-11-06 江西赛基生物技术有限公司 活化血小板的检测方法和检测试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767206A (en) * 1984-12-24 1988-08-30 Flow Cytometry Standards Corporation Calibration method for flow cytometry using fluorescent microbeads and synthesis thereof
US5380663A (en) * 1984-12-24 1995-01-10 Caribbean Microparticles Corporation Automated system for performance analysis and fluorescence quantitation of samples
US5093234A (en) * 1984-12-24 1992-03-03 Caribbean Microparticles Corporation Method of aligning, compensating, and calibrating a flow cytometer for analysis of samples, and microbead standards kit therefor
CA2087086A1 (en) * 1992-01-22 1993-07-23 Leon Wmm Terstappen Multidimensional cell differential analysis
EP0685071A4 (de) * 1993-11-12 2000-12-13 Becton Dickinson Co Verfahren zu absoluter zählung von seltenen zellen
AU689248B2 (en) * 1994-04-11 1998-03-26 Nexins Research B.V. A method for detecting and/or optionally quantifying and/or separating apoptotic cells in or from a sample
US5552290A (en) * 1994-11-14 1996-09-03 University Of Massachusetts Medical Center Detection of procoagulant platelet-derived microparticles in whole blood
FR2795820A1 (fr) * 1999-07-01 2001-01-05 Biocytex Procede de quantification de microparticules endotheliales

Also Published As

Publication number Publication date
CA2410008A1 (fr) 2001-11-22
EP1282817A1 (de) 2003-02-12
DE60110407D1 (de) 2005-06-02
FR2809181A1 (fr) 2001-11-23
JP2003533698A (ja) 2003-11-11
EP1282817B1 (de) 2005-04-27
US20030175831A1 (en) 2003-09-18
DE60110407T2 (de) 2006-03-09
ES2238442T3 (es) 2005-09-01
WO2001088539A1 (fr) 2001-11-22
JP4831915B2 (ja) 2011-12-07
FR2809181B1 (fr) 2002-10-25

Similar Documents

Publication Publication Date Title
ATE294392T1 (de) Reagenz zur bestimmung von blutplättchen- mikroteilchen
RS54004A (en) Photoprotein with improved bioluminescence
ATE528648T1 (de) Verfahren zum nachweis antikörper-herstellender zellen
DE69429770D1 (de) Verfahren und analytisches system zur genauen schnellen und einfachen ausführung von fibrinogen-assays
DE50304023D1 (de) Diagnose von Myokardinfarkt und akutem Koronarsyndrom durch Kombination von Markern
AU9648301A (en) Assay for rapid detection of human activated protein c and highly specific monoclonal antibody therefor
WO2001057522A3 (en) Immunochromatographic methods which employ semiconductor nanocrystals
AU1038402A (en) Assay for directly detecting a rs virus related biological cell in a body fluid sample
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
AU2003224447A1 (en) Device and method to simultaneously detect different antibodies and antigens in clinical alimentary and environmental samples
DE60013320D1 (de) Analytassay-vorrichtung mit vorabsorbieren-zone
ATE432358T1 (de) Kolorimetrische substrate, kolorimetrische sensoren und verwendungsverfahren
TR200103011T2 (tr) Bulaşıcı sünger tipi ansefalopatilerinin teşhisine yönelik metod.
DE60029413D1 (de) Enzymatische messung von mycophenolsäure
NO20052553L (no) Cobalaminanalyse.
NO20006109D0 (no) Analytisk metode som beskytter multippel virusmerking
DE69819643D1 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
ATE384257T1 (de) Energiemessung von photonen von biologischen assays
MXPA01006914A (es) Metodos para identificar combinaciones de entidades como terapeuticas.
WO2006099537A3 (en) The use of antibody-surrogate antigen systems for detection of analytes
AU5572998A (en) Improving performance of binding assays by use of more than one label
DK1214447T3 (da) Påvisning af pyruvatkinase-isoenzymer i fæces
PT918991E (pt) Metodo de ensaio
EP1536233A4 (de) Verfahren zur proteinbestimmung, indikator für die proteinbestimmung und teststück fur die proteinbestimmung
DE60014064D1 (de) Einetenascin-c isoform als marker für neoplasmen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties